New Key Statistics Module, Z-Score and F-Score
SZSE:301277 Key Ratios
Market Cap ¥ M | 3,531.51 |
Enterprise Value ¥ M | 2,687.28 |
P/E(ttm) | 21.05 |
PE Ratio without NRI | 20.77 |
Forward PE Ratio | -- |
Price/Book | 2.35 |
Price/Sales | 5.33 |
Price/Free Cash Flow | 25.02 |
Price/Owner Earnings | 40.84 |
Payout Ratio % | 0.59 |
Revenue (TTM) ¥ M | 663.00 |
EPS (TTM) ¥ | 0.60 |
Beneish M-Score | -1.96 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 14.20 |
y-y EBITDA Growth Rate % | -24.20 |
EV-to-EBIT | 14.25 |
EV-to-EBITDA | 14.25 |
PEG | 1.46 |
Shares Outstanding M | 280.06 |
Net Margin (%) | 25.35 |
Operating Margin % | 26.11 |
Pre-tax Margin (%) | 28.40 |
Quick Ratio | 6.90 |
Current Ratio | 7.09 |
ROA % (ttm) | 10.38 |
ROE % (ttm) | 11.74 |
ROIC % (ttm) | 23.52 |
Dividend Yield % | 3.16 |
Altman Z-Score | 11.52 |
SZSE:301277 Number of Guru Trades
SZSE:301277 Volume of Guru Trades
Gurus Latest Trades with SZSE:301277
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:301277 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Newland Pharmaceutical Co Ltd Insider Transactions
No Available Data